Exercise mimetics & mitochondrial biogenesis

One of 4 mechanistic pathways to 🏃 Endurance & work capacity · 15 options

PGC-1α is the master regulator of mitochondrial biogenesis, and training is how you normally activate it. These compounds argue they can trigger the same transcriptional program pharmacologically. It is the most exciting mechanism class in the Vault and the one furthest from a human trial.

🩸 Is this pathway actually your problem?

Before reaching for an exercise mimetic, rule out the thing that actually limits most people: oxygen carrying capacity and the cofactors the electron transport chain runs on.

Complete Blood Count (CBC) with DifferentialFerritinCoenzyme Q10Carnitine, Total and FreeVitamin B1 (Thiamine)

🏋️ Athletic Performance & Recovery covers these in one panel →

What engages this pathway

Ordered by how directly each one acts on the mechanism above — never by how much trial evidence exists. Each links to its full breakdown with dosing, half-life and vendor.

💉 SLU-PP-332

ERRα agonism activates the same gene program endurance training does. Treated mice ran significantly further with no training. This is the compound Cam names when explaining why mechanism-first matters — the human trial does not exist and the argument is still excellent.

🧪 Theoretical / mechanistic

💉 SLU-PP-915

A more selective successor. Everything about it is inferred from its parent.

🧪 Theoretical / mechanistic

💉 AICAR

Direct AMPK activation — famously turned sedentary mice into endurance performers. The human problem is delivery: it needs gram-scale IV dosing to reach the concentrations that worked in rodents.

🧪 Theoretical / mechanistic

💉 ATX-304

Designed to solve exactly that bioavailability problem. Early human safety data exists; performance data does not.

🧪 Theoretical / mechanistic

💉 Cardarine (oral/inj) Gw-501516

PPARδ agonism shifts muscle toward oxidative fiber type and fat oxidation, sparing glycogen. The rodent endurance data is among the most dramatic ever published — and so is the high-dose carcinogenicity finding.

🧪 Theoretical / mechanistic⚠ Safety flag

💉 SR-9009

REV-ERB agonism increases mitochondrial number and clears damaged ones. The oral bioavailability is essentially zero, so the injectable question is the only honest one.

🧪 Theoretical / mechanistic

💉 MOTS-c

Improves exercise capacity in aged mice via AMPK and metabolic flexibility. Human athletic data is anecdotal.

🧪 Theoretical / mechanistic

💉 ITPP

Increases the efficiency of oxygen release from hemoglobin at the tissue by shifting the dissociation curve — more delivered oxygen from the same hematocrit. Rodent data is strong; it is banned in horse racing for good reason and human safety is uncharacterized.

🧪 Theoretical / mechanistic⚠ Safety flag

💉 Humanin

Mitochondrial-derived peptide with cytoprotective and metabolic effects in animals.

🧪 Theoretical / mechanistic

💉 SS-31

Restores cristae structure and improves ATP production efficiency. Human trials in mitochondrial myopathy show improved exercise capacity — which is the closest thing to a validated mitochondrial ergogenic here.

✅ Clinically validated

🧬 Urolithin A

Mitophagy induction improved muscle endurance in randomized human trials. Modest effect, real data, and the only entry in this pathway with both.

✅ Clinically validated

🧬 PQQ

PGC-1α-mediated mitochondrial biogenesis in cell and animal models. The human endurance trial is missing.

🧪 Theoretical / mechanistic

🧬 Cordyceps

Improves VO2max and time to exhaustion in several small human trials, plausibly via improved oxygen utilization. Militaris is the studied species; sinensis products are frequently mislabelled.

✅ Clinically validated

💉 Bemethyl

A Russian actoprotector — a drug class built specifically around work capacity under hypoxia. The described action is on mitochondrial protein synthesis, raising the enzyme capacity for gluconeogenesis and aerobic metabolism over a course of days rather than stimulating output on the day, which is why it is dosed as a course and not pre-session. Soviet-era military and sport data, essentially none of it replicated in the West.

📊 Correlative

💉 Hypoxen

Formerly Olifen. Its own 2025 review states that human studies are limited and no clinical trial to international standards is available, and that WADA added it to the Monitoring Program in 2023 after documented use by athletes. The proposed mechanism is a list rather than a chain: improved respiratory-chain coupling, inhibition of succinate dehydrogenase, and mitoKATP activation, the first and third pulling opposite ways. Note that inhibiting succinate dehydrogenase is the exact opposite of what Cytoflavin is designed to do.

🧪 Theoretical / mechanistic
Nothing here is ranked by evidence tier. A lot of what works in this space has never had the trial run, and sorting by trial count would bury exactly the compounds you came looking for. The tier is a label. The mechanism is the map.

What actually decides this outcome, in order of size

Training works by producing a transient energy crisis that the cell answers with transcription. A mimetic proposes to produce the answer without the crisis. Ranked by how much of the outcome each factor owns:

  1. Training itself, which is the comparator every compound here is measured against and loses to. This is not a rhetorical point: exercise produces coordinated adaptation across mitochondrial density, capillarity, substrate handling and cardiac output, and no single receptor agonist reproduces that set.
  2. WHETHER THE DRUG COMPETES WITH THE TRAINING SIGNAL, WHICH IS THE DIRECTION QUESTION AND HAS HUMAN DATA. Chronic metformin treatment was studied for its effect on training adaptations in men and women with hyperglycemia Moreno-Cabanas 2022. That is the honest reference point for this entire page: the best-studied energy-sensing drug in humans was examined for whether it interferes with adaptation rather than adding to it. A page that lists eight mimetics and never raises that possibility has assumed the answer.
  3. What AMPK activation actually does in a human, as opposed to a mouse. AICAR was the founding demonstration that exercise-like transcription can be induced pharmacologically Narkar 2008; in humans it has been given during hyperinsulinemia with systemic hemodynamic effects Bosselaar 2011, studied for glucose transport Koistinen 2003 and used in metabolic investigation Babraj 2009. Those are physiological studies, not training trials, and the difference is the whole gap on this page. A newer direct AMPK activator has preclinical characterization Katerelos 2024.
  4. Whether the compound is orally active at all, which for one flagship item it is not. SR9009 was shown to have REV-ERB-independent effects Dierickx 2019, which undercuts the mechanism it is sold on, and its in vitro metabolism has been characterized Geldof 2016. A compound with poor oral exposure and off-target activity is not a clean test of the hypothesis it is named for.
  5. The regulatory and safety status, which for the peroxisome-proliferator agonist is decisive. Cardarine has been comprehensively characterized as a doping agent Trevisiol 2021 Kintz 2021, and its development was discontinued on preclinical toxicology grounds. That is the reason it is available only through channels with no dose control.
  6. Whether the mitochondrial peptide arm has a human read-out. MOTS-c was reported to interact synergistically with exercise intervention in a model Yang 2021, which is the most training-relevant claim in this family and is preclinical. Inositol trispyrophosphate is detectable in plasma and urine in equine work Wong 2012, which is a detection literature rather than a performance one.

The order to run these in, and what has to be true first

Everything below is ordered by how much is known in humans doing training, which is the question the page is actually about — and by that measure the ordering is unflattering.

  1. Train, and measure the training. A repeatable submaximal test and a training log are the control arm for everything else on this page, and without them no compound below can be evaluated at all.
  2. Baseline safety bloods before any research compound. A Comprehensive Metabolic Panel (CMP), Lipid Panel (Cholesterol, HDL, LDL, Triglycerides), Complete Blood Count (CBC) with Differential and hs-CRP (High-Sensitivity C-Reactive Protein). These are unlicensed molecules with no healthy-adult safety programs, and liver chemistry and lipids are where the earliest signals in this class have historically appeared.
  3. Urolithin A and PQQ are the two items here that are food-derived and have human tolerability behind them. The urolithin producer-phenotype question is documented Tomas-Barberan 2014, and both belong to mitochondrial quality control more than to biogenesis — see Autophagy & mitochondrial quality control.
  4. Cordyceps and Bemethyl are the traditional and Soviet-era ends of the shelf. Bemethyl's biotransformation has been investigated Belinskaia 2021, which is more than can be said for several items above it, and neither has a modern controlled training trial.
  5. AICAR is the mechanism's origin and is not a practical product. The transcriptional demonstration is real Narkar 2008 and the human work is metabolic rather than performance Bosselaar 2011 Koistinen 2003 Babraj 2009. It is given intravenously in those studies, which is the practical objection.
  6. ATX-304 is the modern direct AMPK activator and is preclinical Katerelos 2024. SLU-PP-332 and SLU-PP-915 are estrogen-related receptor agonists at an earlier stage still, and the honest description of both is that no human has been studied on a training endpoint.
  7. SR-9009 and Cardarine (oral/inj) Gw-501516 are the two items with specific reasons to decline them. SR9009 has REV-ERB-independent activity Dierickx 2019 and metabolism that undercuts oral use Geldof 2016; cardarine's development history and doping-control characterization are the record Trevisiol 2021 Kintz 2021. Both are also banned in tested sport.
  8. MOTS-c, Humanin, SS-31 and ITPP are the peptide arm. The exercise-synergy result is preclinical Yang 2021; ITPP appears in the doping-detection literature Wong 2012. Nothing here has a controlled human training outcome.

What gets bought for this that cannot move it

The category that fails structurally is the mimetic taken alongside serious training in the belief that the two add up. The adaptation signal is the energy deficit training creates. A drug that relieves that deficit pharmacologically is not adding a second stimulus; it may be reducing the first. The most relevant human study asked exactly this of chronic metformin and training adaptation Moreno-Cabanas 2022, and the same logic is why high-dose antioxidants blunt training adaptation in humans Paulsen 2014. Two different classes, one direction problem: suppressing the signal the training was generating.

The evidence failure is the gap between transcription and performance. Every compound here can be shown to change gene expression or a metabolic measure Narkar 2008 Koistinen 2003 Katerelos 2024 Yang 2021. None has a controlled trial in trained humans reporting a performance endpoint. That is not a small gap. It is the entire distance between a mechanism and a product, and this page is the one on the site where it is widest.

Two specific reasons to decline two specific items. SR9009's effects have been shown to be partly REV-ERB-independent Dierickx 2019 and its metabolism argues against oral use Geldof 2016 — so a person taking it orally for a REV-ERB effect is probably getting neither. Cardarine's presence in the doping-control literature Trevisiol 2021 Kintz 2021 exists because its development stopped for toxicology reasons, and no amount of forum confidence changes that record.

If the goal underneath is different, so is the page. If the limit is oxygen delivery, Oxygen delivery & nitric oxide. If it is buffering, Buffering & fatigue resistance. If it is fuel, Substrate & fuel availability. If it is ATP production in a person who is not training, Mitochondrial ATP production. And any tested athlete should treat this entire page as a list of prohibited substances Kintz 2021 Wong 2012 rather than as a shelf.

How you would know it was working, on a real read-out and a real timescale

This page makes two predictions. A fixed submaximal test will detect a real mitochondrial adaptation within eight to twelve weeks because that is how long the training version takes; and nothing here will produce that change without training, which is the claim the whole category rests on and the one nobody has tested in humans.

  • A fixed submaximal test, three repeats before and three during, at eight and twelve weeks. Heart rate and perceived effort at a set pace. Three repeats because day-to-day variation exceeds the plausible effect, and eight to twelve weeks because mitochondrial adaptation to training runs on that timescale.
  • Comprehensive Metabolic Panel (CMP) with a Lipid Panel (Cholesterol, HDL, LDL, Triglycerides) at baseline and 12 weeks on any research compound. Transaminases and lipids are where the earliest problems in this class have shown up, and these are molecules without healthy-adult safety data.
  • Complete Blood Count (CBC) with Differential with Ferritin at baseline and 12 weeks. Iron status is the commonest reason a training block stops producing adaptation, and it is a far more likely explanation for a plateau than an absent mimetic effect.
  • hs-CRP (High-Sensitivity C-Reactive Protein) and Uric Acid at baseline and 12 weeks. Cheap systemic markers on a page of unlicensed compounds; a rise in either is a reason to stop rather than a sign of adaptation.
  • HbA1c (Hemoglobin A1c) at baseline and 12 weeks if an AMPK-directed compound is being run. The class's best-documented human effects are metabolic rather than performance-related Koistinen 2003 Bosselaar 2011, so this is where an effect would actually appear.

What will fool you. A training block started at the same time as a compound will produce the adaptation and hand the credit to the capsule — which is why the three baseline tests come first. Fresh legs after a taper feel like a drug working. Preclinical synergy with exercise Yang 2021 is a model result and not a training week. A compound bought from an unregulated source may not contain what the label says, and the doping-control literature exists partly because identity in this market is unreliable Trevisiol 2021 Geldof 2016. And antioxidants taken for recovery through the same block may be reducing the adaptation being measured Paulsen 2014.

Sources read for these sections

The other 3 routes to endurance & work capacity

Pick the pathway that matches where you are actually stuck. An appetite drug does nothing for someone who already undereats.

Oxygen delivery & nitric oxide13 optionsBuffering & fatigue resistance10 optionsSubstrate & fuel availability12 options

You know the goal. Skool has the plan.

This pathway is one arm of The Endurance & work capacity Blueprint. The members' version has where this arm sits in the sequence, what to stack it with, and the markers that tell you to keep going or stop.

Open The Endurance & work capacity Blueprint in Skool →

$10/mo, cancel anytime.

← Open this pathway in the interactive Vault

Frequently asked questions

What is the exercise mimetics & mitochondrial biogenesis pathway for endurance & work capacity?

PGC-1α is the master regulator of mitochondrial biogenesis, and training is how you normally activate it. These compounds argue they can trigger the same transcriptional program pharmacologically. It is the most exciting mechanism class in the Vault and the one furthest from a human trial.

What compounds and supplements work through exercise mimetics & mitochondrial biogenesis?

15 options are mapped to this pathway in the Vault, including SLU-PP-332, SLU-PP-915, AICAR, ATX-304. They are grouped by the mechanism they act through rather than ranked by how much trial evidence exists — 3 carry clinical validation and 11 are mechanistic predictions.

How do I know if exercise mimetics & mitochondrial biogenesis is actually my problem?

Before reaching for an exercise mimetic, rule out the thing that actually limits most people: oxygen carrying capacity and the cofactors the electron transport chain runs on. The markers worth checking are Complete Blood Count (CBC) with Differential, Ferritin, Coenzyme Q10, Carnitine, Total and Free.

Are the 11 theoretical options for exercise mimetics & mitochondrial biogenesis worth considering?

Unproven is not the same as ineffective. Of the 15 options on this pathway, 3 have clinical validation and 11 are graded theoretical — meaning the mechanism is sound but the specific human trial has not been run, which is true of a great deal of what works in this space. Nothing on this page is ordered by evidence tier, because sorting by trial count would bury the compounds you came looking for.

Where this goes next

Test itAthletic Performance & RecoveryThe panel that says whether this is your problemGo deeperThe Endurance BlueprintThe free week-by-week structure behind this goal
The full protocol$10/mo

Everything above is the free case for Exercise mimetics & mitochondrial biogenesis. The protocol — the dosing, the order to correct things in, the week-by-week schedule and what to retest — is a lesson inside Skool.

The Endurance Blueprint
Educational and research reference only — not medical advice, and not a recommendation for human use. Mechanistic predictions are exactly that: what the biology suggests should happen, which is not the same as what has been shown to happen.

↑ Back to on this page

The blueprint this pathway sits insideThe Endurance Blueprint →The full 12-week stack this pathway belongs to — every arm, the sequence, and the bloodwork.